Headquartered in Tampa, FL Fiscal year ends December NASDAQ: AIRS airsculpt.com
AirSculpt Technologies is a national provider of premium, minimally invasive body contouring procedures available exclusively at its AirSculpt-branded offices across the United States. The company's proprietary AirSculpt procedure removes fat, tightens skin, and sculpts targeted body areas with minimal bruising and quick healing times. As of June 30, 2026, AirSculpt operated 31 facilities with 65 procedure rooms. The company generates revenue on a per-case basis, with an average revenue per case of approximately $12,707. AirSculpt recently expanded its treatment platform through an exclusive partnership with AlloClae to offer an injectable adipose matrix, broadening its addressable patient population beyond traditional liposuction-style procedures. The company trades on NASDAQ under the ticker AIRS. Updated
Have you considered investing in penny stocks? While they are risky, they can also produce meaningful returns. That is, as long as you make the right picks. Penny stocks represent small publicly…
AirSculpt Technologies is a national provider of premium, minimally invasive body contouring procedures available exclusively at its AirSculpt-branded offices across the United States.
The Wall Street consensus 12-month price target for AIRS is $4.50.
